Home » Newsletters » BioWorld

BioWorld

Dec. 28, 2009

View Archived Issues

'Cinderella' OncoGenex, Ambit Want Top Billing with Princes

Last week's flurry of partnering deals included a few unexpected matchups. Read More

ADCs: Missing 'Link' for Efficacy Gains Ground in Oncology Bids

Money Raised Year to Date

Money Raised By Biotech in 2009

Week in Review

Word on the Street

Week in Washington

Biotechnology Company Deals With Other Biotechnology Companies: Nov. 1 - Dec. 23, 2009

Biotechnology Company Deals With Miscellaneous Companies: Nov. 1 - Dec. 23, 2009

Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Nov. 1 - Dec. 23, 2009

Biotech - Biotech Collaborations: Modified Agreements: Nov. 1 - Dec. 23, 2009

Stock Gainers and Losers For The Week

BioWorld Stock Report For Public Biotechnology Companies

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...